Hostname: page-component-586b7cd67f-rdxmf Total loading time: 0 Render date: 2024-11-22T06:30:21.988Z Has data issue: false hasContentIssue false
  • English
  • Français

The Economic Impact of Tuberculosis in Hospitals in New York City: A Preliminary Analysis

Published online by Cambridge University Press:  01 January 2021

Peter S. Arno ,
Christopher J.L. Murray ,
Karen A. Bonuck  and
Philip Alcabes
Get access Rights & Permissions [Opens in a new window]

Extract

There is a nationwide resurgence of tuberculosis (TB) in the country’s urban centers; New York City stands at the forefront of this resurgence. The root causes are increased homelessness, drug addiction and poverty, all symbols of deteriorating social and economic conditions in the city. The inadequate level of public health resources devoted to TB has also contributed to its spread. Still, even with these factors, it is questionable whether the escalating number of TB cases in this country would have occurred without the reservoir of immunosuppressed persons, who are less resistant to the disease, created by the AIDS epidemic. The fear and urgency of this public health crisis, which has been emerging since the beginning of the last decade, are fueled by the rise of TB strains resistant to the first-line drugs and by the disease’s contagiousness.

Type
Article
Information
Journal of Law, Medicine & Ethics , Volume 21 , Issue 3-4 , Fall Winter 1993 , pp. 317 - 323
Copyright
Copyright © American Society of Law, Medicine and Ethics 1993

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

This study was supported by the Edna McConnell Clark Foundation, the Robert Wood Johnson Foundation, and the Health Services Improvement Fund. We gratefully acknowledge computer programming support from Jiming Chen and the helpful comments of Barry Bloom, Pamela McMaster, Phyllis Lantos, Fran R. Lawffer and Karyn Feiden who reviewed earlier versions of this manuscript. Any errors are the sole responsibility of the authors.Google Scholar
Centers for Disease Control, “Tuberculosis Cases and Case Rates: Cities of 250,000 population, 1992 and 1991,” memorandum, May 1993.Google Scholar
New York City Department of Health, “Purposes of Encounters, Chest Clinics: 4/01/91-4/30/92,” Unpublished data; HHC internal memorandum, September 17, 1992.Google Scholar
Jereb, J.A., Kelly, G.D., Dooley, S.W. et al., “Tuberculosis Morbidity in the United States: Final Data, 1990,” MMWR CDC Surveillance Summary, 40(ss-3)(1992): 23–7.Google Scholar
U.S. Department of Health and Human Services. 1989 Tuberculosis Statistics in the United States, August 1991.Google Scholar
Pitchenik, A.E., Fertel, D., Bloch, A.B., “Mycobacterial Disease: Epidemiology, Diagnosis, Treatment, and Prevention,” Clin Chest Med, 9 (1988): 425–41.Google Scholar
Barnes, P.F., Bloch, A.B., Davidson, P.T., Snider, D.E. Jr., “Tuberculosis in Patients with Human Immunodeficiency Virus Infection,” N Engl J Med, 132 (1991): 1644–50.CrossRefGoogle Scholar
Centers for Disease Control, National HIV seroprevalence surveys: Summary of Results, Data from Sero-Surveillance Activities through 1989, U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, HIV/ CID 19-90/006, June 1990.Google Scholar
Selwyn, P.A., Hartel, D., Lewis, V.A. et al., “A Prospective Study of the Risk of Tuberculosis among Intravenous Drug Users with Human Immunodeficiency Syndrome,” N Engl J Med, 320 (1989): 545–50.CrossRefGoogle Scholar
Hobby, G.L., Johnson, P.M., Lenert, T.F. et al., “A Continuing Survey of Primary Drug Resistance in Tuberculosis in a Veteran Population within the United States,” Amer Rev Respir Dis, 89 (1964): 337–49; Centers for Disease Control, “Primary Resistance to Antituberculosis Drugs—United States,” MMWR 32 (1983): 521-3.Google Scholar
Snider, D.E., Roper, W.L., “The New Tuberculosis,” N Engl J Med, 326 (1992): 703–5.CrossRefGoogle Scholar
Iseman, M.D. and Madsen, L.A., “Drug-Resistant Tuberculosis.” Clin Chest Med, 10 (1989): 341.Google ScholarPubMed
Frieden, T.R., Sterling, T., Pablos-Mendez, A. et al., “The Emergence of Drug-Resistant Tuberculosis in New York City,” N Engl J Med, 328 (1993): 521–6.CrossRefGoogle Scholar
Cohn, D.L., Catlin, B.J. et al., “A 62–dose, 6–month Therapy for Pulmonary and Extrapulmonary Tuberculosis,” Ann Intern Med, 112 (1990): 407–15; Snider, D.E., Caras, G.J., Koplan, J.P., “Preventive Therapy with Isoniazid: Cost Effectiveness of Different Durations of Therapy,” JAMA, 255 (1986): 1579–1583; Barnum, H.N., “Cost Savings from Alternative Treatments for Tuberculosis,” Soc Sci Med, 23 (1986): 847-50.CrossRefGoogle Scholar
Murray, C.J.L., DeJonghe, E. et al., “Cost-Effectiveness of Chemotherapy for Pulmonary Tuberculosis in Three Sub-Saharan Countries,” Lancet 338 (1991): 1305–8.CrossRefGoogle Scholar
Bloom, B.R., Murray, C.J.L., “Tuberculosis: Commentary on a Reemergent Killer,” Science, 257 (1992): 1055–64.CrossRefGoogle Scholar
Greater New York Hospital Association, Skyline News, April 12, 1993.Google Scholar
Centers for Disease Control, “Outbreak of MDR-TB—Texas, California, and Pennsylvania,” MMWR, 39 (1990): 369–372.Google Scholar
Kizer, K.W., Keith, J., Hiehle, G. et al., AIDS in California: Expenditures, Demographics and Mortality for Persons with AIDS on Medi-Cal (Sacramento: California Department of Health Services, 1988); Hamidi, C., Hidalgo, J., Evaluation of ICD-9-CM Coding Nets in AIDS Case Surveillance and Health Services Research (Baltimore: Maryland Department of Health and Mental Hygiene, AIDS Administration, 1989); Keyes, M., Andrews, R., Mason, M., “A Methodology for Building an AIDS Research File Using Medicaid Claims and Administrative Data Bases,” J AIDS 4 (1991): 1015-1024.Google Scholar
Greater New York Hospital Association, Engineering Solutions for TB Risk Areas, draft. January 1993.Google Scholar
Personal communication with Dr.Alpert, Peter, Montefiore Medical Center, July 28, 1993.Google Scholar
Green, J., Arno, P.S., “The ‘Medicaidization’ of AIDS: Trends in the Financing of HIV Related Medical Care,” JAMA 264 (1990): 1261–1266.CrossRefGoogle Scholar
United Hospital Fund, Health Care Annual: An Update on Trends and Facilities in New York (New York, NY: United Hospital Fund, 1990).Google Scholar
New York State Department of Health, Tuberculosis Control in Hospitals, July 1992.Google Scholar
New York State SPARCS, Annual Report Series for 1990 (Albany, NY: Department of Health, 1991).Google Scholar
Brudney, K., Dobkin, J., “Resurgent Tuberculosis in New York City,” Amer Rev Respir Dis, 144 (1991): 745–749.CrossRefGoogle Scholar
McDonald, R.J. et al., “Successful Supervised Ambulatory Management of Tuberculosis Treatment Failures,” Ann Intern Med, 96 (1982): 297–302.CrossRefGoogle Scholar
Dubler, N.N., Bayer, R., Landesman, S., White, A., “A Report from the Working Group on Tuberculosis and HIV,” In The Tuberculosis Revival: Individual Rights and Societal Obligation in a Time of AIDS (New York: United Hospital Fund, 1992).Google Scholar